Advance prescription drug reforms to cut drug prices.

Chuck Grassley · Iowa · Republican

policy impact 0.82 specificity 0.78 extraction confidence 97%

Contest this claim

Occurrences

Bipartisan prescription drug reform to cut drug prices

Grassley commits to pursuing bipartisan prescription drug reform aimed at lowering drug prices.

Issues - Senator Chuck Grassley
campaign · campaign_site · model gpt-5.5

Evidence

The campaign page said Grassley worked to lower drug prices through bipartisan legislation and listed as future work: “Bipartisan prescription drug reform to cut drug prices.”

Establishes the campaign-side promise that Grassley would pursue bipartisan prescription drug reforms aimed at lowering prices.

unresolved unknown

FACT CHECK: Drug Pricing - Grassley Works
campaign · model gpt-5.5 · confidence 90%

Contest this evidence item

Congress.gov lists Grassley as an original cosponsor of S.127. The bill would restrict PBM practices, require PBM reporting to the FTC, and authorize FTC and state attorney general enforcement. It was ordered reported favorably and placed on the Senate legislative calendar, but not enacted in the 118th Congress.

Shows concrete same-term action to advance drug-price/PBM reform, though the 2023 bill did not become law.

partial same_term A for effort

S.127 - Pharmacy Benefit Manager Transparency Act of 2023
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

Grassley’s Senate office said he was an original cosponsor of the PBM Price Transparency and Accountability Act and that Grassley-led provisions would increase PBM reporting, require NADAC survey participation, and ban PBM spread pricing in Medicaid.

Connects Grassley to specific PBM accountability provisions later relevant to enacted 2026 appropriations legislation.

partial same_term A for effort

Key Grassley Provisions Included in New Bipartisan Legislation to Lower Prescription Drug Costs and Make Health Care More Affordable
secondary · model gpt-5.5 · confidence 87%

Contest this evidence item

Congress.gov records H.R.7148 as Public Law 119-75. The enrolled text includes PBM accountability provisions, including requirements for Part D PBM agreements, limits on PBM remuneration to bona fide service fees, pass-through treatment for rebates and discounts, reporting, audit rights, and enforcement funding.

Official bill text and status show that federal PBM prescription-drug reforms became law during Grassley’s post-2022 Senate term.

delivered same_term A for effort

H.R.7148 - Consolidated Appropriations Act, 2026
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

The official Senate roll call shows H.R.7148 passed the Senate 71-29 on January 30, 2026, and lists Grassley (R-IA) voting Yea.

Shows Grassley voted for the appropriations bill that became law and included PBM prescription drug reforms.

delivered same_term A for effort

U.S. Senate Roll Call Vote 119th Congress - Vote 20 on H.R.7148
secondary · model gpt-5.5 · confidence 95%

Contest this evidence item

Assessments

delivered same_term A for effort

Grassley promised to advance bipartisan prescription-drug reforms to cut prices. During the same post-2022 Senate term, he cosponsored PBM/drug-pricing reform legislation, publicly backed related PBM accountability provisions, and voted Yea on H.R.7148, which became Public Law 119-75 on February 3, 2026 and included enacted PBM prescription-drug reforms such as reporting, audit rights, rebate/discount pass-through treatment, and limits on PBM remuneration. Because relevant reforms became law in the same term, the promise is best classified as delivered.

provider codex_cli · model gpt-5.5 · confidence 91%